PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis.
Julià A, Rodríguez J, Fernández-Sueiro JL, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Manrique-Arija S, Muñoz-Fernández S, González C, Roig D, Zarco P, Erra A, Castañeda S, García A, Salvador G, Díaz-Torne C, Blanco R, Domínguez AW, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, Avila G, Alonso A, Tortosa R, López-Lasanta M, Cañete JD, Marsal S.
Julià A, et al. Among authors: tornero j.
Pharmacogenomics. 2014 Nov;15(14):1763-1769. doi: 10.2217/pgs.14.125.
Pharmacogenomics. 2014.
PMID: 25493569